December 10th 2025 CoP Psychedelics and the Use in Treatment of Mental Health

There is growing interest in the use of psychedelics for the treatment of PTSD, depression and substance use disorders. Patients may ask their provider about these options, but family physicians are unaware of the latest data on safety and efficacy or understand what services are available in Ontario. During this session, our panelist will discuss the current evidence for specific treatments in PTSD, depression and substance use disorders, including the limitations of the evidence and risks of these therapies, and pathways for referrals and treatment.  Panelists:  Dr. Monique Moller Dr. Sabrina Akhtar  Dr. Prachi Soneji  Moderator: Dr. Stephanie Zhou, Addictions Medicine Physician and EDI & Social Accountability Lead, Sunnybrook Hospital; FHO Lead, Don Mills FHT; Assistant Professor, University of Toronto Faculty of Medicine; Board Director, Toronto Public Health, Toronto, ON  Co-Host:  Dr. Nikki Bozinoff, Division Head, Mental Health and Addictions, Department of Family and Community Medicine, University of Toronto; Physician, Concurrent Outpatient Medical and Psychosocial Addiction Support Service, Centre for Addiction and Mental Health   This session took place on December 10 2025. A Video recording is also available